{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:41:35Z","timestamp":1781534495880,"version":"3.54.5"},"reference-count":247,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust N Z J Psychiatry"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    The Royal Australian and New Zealand College of Psychiatrists (RANZCP) is co-ordinating the development of clinical practice guidelines (CPGs) in psychiatry, funded under the National Mental Health Strategy (Australia) and the New Zealand Ministry of Health.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Method:<\/jats:bold>\n                    The CPG team reviewed the treatment outcome literature, consulted with practitioners and patients and conducted meta-analyses of outcome research.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Treatment recommendations:<\/jats:bold>\n                    Establish an effective therapeutic relationship; provide the patient with information about the condition, the rationale for treatment, the likelihood of a positive response and the expected timeframe; consider the patient's strengths, life stresses and supports. Treatment choice depends on the clinician's skills and the patient's circumstances and preferences, and should be guided but not determined by these guidelines. In moderately severe depression, all recognized antidepressants, cognitive behavioural therapy (CBT) and interpersonal psychotherapy (IPT) are equally effective; clinicians should consider treatment burdens as well as benefits, including side-effects and toxicity. In severe depression, antidepressant treatment should precede psychological therapy. For depression with psychosis, electroconvulsive therapy (ECT) or a tricyclic combined with an antipsychotic are equally helpful. Treatments for other subtypes are discussed. Caution is necessary in people on other medication or with medical conditions. If response to an adequate trial of a first-line treatment is poor, another evidence-based treatment should be used. Second opinions are useful. Depression has a high rate of recurrence and efforts to reduce this are crucial.\n                  <\/jats:p>","DOI":"10.1080\/j.1440-1614.2004.01377.x","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T18:43:15Z","timestamp":1260211395000},"page":"389-407","source":"Crossref","is-referenced-by-count":95,"title":["Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression"],"prefix":"10.1177","volume":"38","author":[{"name":"Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Depression","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,6,26]]},"reference":[{"key":"e_1_3_2_2_1","first-page":"S77","article-title":"Treating depression: the beyondblue guidelines for treating depression in primary care. \u2018Not so much what you do but that you keep doing it\u2019","volume":"176","author":"Ellis P M","year":"2002","unstructured":"1. Ellis P M, Smith D AR. Treating depression: the beyondblue guidelines for treating depression in primary care. \u2018Not so much what you do but that you keep doing it\u2019. Medical Journal of Australia 2002; 176(Suppl.)S77\u2013S83.","journal-title":"Medical Journal of Australia"},{"key":"e_1_3_2_3_1","volume-title":"Guidelines for the treatment and management of depression by primary healthcare professionals","author":"National Health Committee","year":"1996","unstructured":"2. National Health Committee. Guidelines for the treatment and management of depression by primary healthcare professionals. Ministry of Health, Wellington 1996."},{"key":"e_1_3_2_4_1","volume-title":"Getting up from feeling down: young people and depression","author":"Health and Medical Research Council","year":"1997","unstructured":"3. Health and Medical Research Council. Getting up from feeling down: young people and depression. National Health and Medical Research Council, Canberra 1997."},{"key":"e_1_3_2_5_1","volume-title":"Brief report provided to the New Zealand Treasury on the prevalence and disability of DSM-IV disorders from the 1997 Australian National Survey of Mental Health and Well-being","author":"Andrews G","year":"2000","unstructured":"4. Andrews G. Brief report provided to the New Zealand Treasury on the prevalence and disability of DSM-IV disorders from the 1997 Australian National Survey of Mental Health and Well-being. New Zealand Treasury, Wellington 2000."},{"key":"e_1_3_2_6_1","volume-title":"Mental health and wellbeing: profile of adults, Australia 1997","author":"McLennan W","year":"1998","unstructured":"5. McLennan W. Mental health and wellbeing: profile of adults, Australia 1997. Australian Bureau of Statistics, Canberra 1998."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430070062031"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950130011002"},{"key":"e_1_3_2_9_1","volume-title":"The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020","author":"Murray C JL","year":"1996","unstructured":"8. Murray C JL, Lopez A D. The global burden of disease: a comprehensive assessment of mortality and disability from disease, injuries and risk factors in 1990 and projected to 2020, Murray C JL, Lopez A D. Harvard University Press, Cambridge, MA 1996."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048678409158781"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390170008002"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199201000-00009"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048679409075849"},{"key":"e_1_3_2_14_1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn","author":"American Psychiatric Association","year":"1994","unstructured":"13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. American Psychiatric Press, Washington, DC 1994."},{"key":"e_1_3_2_15_1","volume-title":"Treatment of depression: Newer pharmacotherapies: AHCPR","author":"Mulrow C D","year":"1999","unstructured":"14. Mulrow C D, Williams J W, Trivedi M, Chiquette E, Aguilar C, Cornell J E. Treatment of depression: Newer pharmacotherapies: AHCPR. Agency for Healthcare Policy and Research, Rockville, MD 1999."},{"key":"e_1_3_2_16_1","first-page":"399","article-title":"Double depressive disorder, major depressive disorder and dysthymic disorder. Distinct entities or different phases of a single disorder?","volume":"20","author":"Keller M B","year":"1984","unstructured":"15. Keller M B, Lavori P W. Double depressive disorder, major depressive disorder and dysthymic disorder. Distinct entities or different phases of a single disorder?. Psychopharmacology Bulletin 1984; 20: 399\u2013402.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820100053010"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.153.6.741"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.8.694"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199504040-00004"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291701004743"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.172.1.35"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.7.849"},{"key":"e_1_3_2_24_1","first-page":"171","volume-title":"Sucide: understanding and responding","author":"Hyman S","year":"1990","unstructured":"23. Hyman S, Arana G W. Suicide and affective disorder. Sucide: understanding and responding, Jacobs D BH. International University Press, Madison 1990; 171\u2013181."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1986.tb27909.x"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb01318.x"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(96)00050-X"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.3.259"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.2.190"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.2.168"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.2.181"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.7.1002"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7151.115"},{"key":"e_1_3_2_34_1","first-page":"863","article-title":"The prediction of Major Depression in women: Towards an integrated aetiological model","volume":"150","author":"Kendler K S","year":"1993","unstructured":"33. Kendler K S, Kessler R C, Neale M C, Heath A C, Eaves L J. The prediction of Major Depression in women: Towards an integrated aetiological model. American Journal of Psychiatry 1993; 150: 863\u2013870.","journal-title":"American Journal of Psychiatry"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.163.6.733"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.163.6.739"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.165.4.447"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.165.4.457"},{"issue":"1","key":"e_1_3_2_39_1","first-page":"17","article-title":"Treatment of severe depression","volume":"61","author":"Thase M E","year":"2000","unstructured":"38. Thase M E. Treatment of severe depression. Journal of Clinical Psychiatry 2000; 61(Suppl.1)17\u201325.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700027860"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700001975"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90063-E"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420150079041"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00313-6"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/106286060101600205"},{"key":"e_1_3_2_46_1","first-page":"718","article-title":"Relation of stressors and depressive symptoms to clinical progression of viral illness [Comment]","volume":"154","author":"Zorrilla E P","year":"1996","unstructured":"45. Zorrilla E P, McKay J R, Luborsky L, Schmidt K. Relation of stressors and depressive symptoms to clinical progression of viral illness [Comment]. American Journal of Psychiatry 1996; 154: 718.","journal-title":"American Journal of Psychiatry"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462971920000"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(95)00615-X"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200201000-00004"},{"key":"e_1_3_2_50_1","first-page":"S25","article-title":"Depression in the patient with chronic pain","volume":"43","author":"Ruoff G E","year":"1996","unstructured":"49. Ruoff G E. Depression in the patient with chronic pain. Journal of Family Practice 1996; 43(Suppl.)S25\u2013S33.","journal-title":"Journal of Family Practice"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_3_2_52_1","first-page":"873","article-title":"Comparative analysis of two rates","volume":"17","author":"Mietinnen O","year":"1985","unstructured":"51. Mietinnen O, Nurminnen M. Comparative analysis of two rates. Statistics in Medicine 1985; 17: 873\u2013890.","journal-title":"Statistics in Medicine"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/014662167700100306"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(03)00039-1"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00232-9"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300730-00006"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00007"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.3.233"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.3.219"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.174.3.225"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6977.441"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7226.26"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/57.1.115"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta4190"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101005343.x"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.2.95"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790120037006"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820100018004"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0510"},{"key":"e_1_3_2_71_1","volume-title":"The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging","author":"American Psychiatric Association","year":"1990","unstructured":"70. American Psychiatric Association. The practice of electroconvulsive therapy: Recommendations for treatment, training and privileging. American Psychiatric Press, Washington, DC 1990."},{"key":"e_1_3_2_72_1","volume-title":"The ECT handbook","author":"Freeman C P","year":"1995","unstructured":"71. Freeman C P. The ECT handbook. Gaskell, London 1995, (Council report CR39)."},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00096-8"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.146.6.576"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70353-1"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.8.723"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/10673229809003578"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.176.4.363"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260037004"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.5.431"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00002"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.3.306"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220051006"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(80)90019-0"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.3.328"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198210000-00008"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197912000-00002"},{"key":"e_1_3_2_88_1","first-page":"184","article-title":"Pharmacological treatment of delusional depressives","volume":"18","author":"Spiker D G","year":"1982","unstructured":"87. Spiker D G, Hanin I, Perel J M, Cofsky J E, Rossi A J, Sorisio D. Pharmacological treatment of delusional depressives. Psychopharmacology Bulletin 1982; 18: 184\u2013186.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.4.430"},{"key":"e_1_3_2_90_1","first-page":"462","article-title":"Depression, delusions and drug response","volume":"132","author":"Glassman A H","year":"1975","unstructured":"89. Glassman A H, Kantor S J, Shostak M. Depression, delusions and drug response. American Journal of Psychiatry 1975; 132: 462\u2013463.","journal-title":"American Journal of Psychiatry"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.131.5.493"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.1979.136.4b.559"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00079-8"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.4.381"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.3.241"},{"key":"e_1_3_2_96_1","volume-title":"Prescribing medicines in pregnancy. An Australian categorization of risk of drug use in pregnancy 4th edn","author":"Medicines in Pregnancy Working Party of the Australian Drug Evaluation Committee","year":"1999","unstructured":"95. Medicines in Pregnancy Working Party of the Australian Drug Evaluation Committee. Prescribing medicines in pregnancy. An Australian categorization of risk of drug use in pregnancy 4th edn. Therapeutic Goods Administration, Canberra 1999."},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200002030-00003"},{"key":"e_1_3_2_98_1","first-page":"17","volume":"11","author":"Anonymous. Drugs and breast feeding","year":"2002","unstructured":"97. Anonymous. Drugs and breast feeding. Prescribe International 2002; 11: 17.","journal-title":"Prescribe International"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00332-3"},{"issue":"8","key":"e_1_3_2_100_1","first-page":"64","article-title":"Consensus statement on depression, anxiety, and oncology","volume":"62","author":"Ballenger J C","year":"2001","unstructured":"99. Ballenger J C, Davidson J R, Lecrubier Y, . Consensus statement on depression, anxiety, and oncology. Journal of Clinical Psychiatry 2001; 62(Suppl.8)64\u201367.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_101_1","article-title":"Database of systematic reviews (4)","author":"Gill D","year":"2000","unstructured":"100. Gill D, Hatcher S. Database of systematic reviews (4). Cochrane Database of Systematic Reviews CD001312 2000.","journal-title":"Cochrane Database of Systematic Reviews CD001312"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.109977"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212010-00006"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690596"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.3109\/10673229809000307"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.3.221"},{"issue":"15","key":"e_1_3_2_107_1","first-page":"13","article-title":"Cardiovascular effects of antidepressant drugs: updated","volume":"59","author":"Glassman A H","year":"1998","unstructured":"106. Glassman A H. Cardiovascular effects of antidepressant drugs: updated. Journal of Clinical Psychiatry 1998; 59(Suppl.15)13\u201318.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.006"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/hrp\/7.2.85"},{"key":"e_1_3_2_110_1","first-page":"289","article-title":"Seizures associated with antidepressants: a review","volume":"54","author":"Rosenstein D L","year":"1993","unstructured":"109. Rosenstein D L, Nelson J C, Jacobs S C. Seizures associated with antidepressants: a review. Journal of Clinical Psychiatry 1993; 54: 289\u2013299.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(87)72555-9"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.102004250.x"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb10145.x"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01572_1.x"},{"key":"e_1_3_2_115_1","first-page":"2","article-title":"Transcranial magnetic stimulation for treating depression","author":"Martin J L","year":"2002","unstructured":"114. Martin J L, Barband M J, Schlaepfer T E, . Transcranial magnetic stimulation for treating depression. Cochrane Database of Systematic Reviews CD003493 2002; 2.","journal-title":"Cochrane Database of Systematic Reviews CD003493"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.102001003.x"},{"key":"e_1_3_2_117_1","first-page":"3","article-title":"Tryptophan and 5-hydroxytryptophan for depression","author":"Shaw K","year":"2003","unstructured":"116. Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews 2003; 3.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_3_2_118_1","first-page":"S84","article-title":"Effectiveness of complementary and self-help treatments for depression","volume":"176","author":"Jorm A F","year":"2002","unstructured":"117. Jorm A F, Christensen H, Griffiths K M, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Medical Journal of Ausstralia 2002; 176(Suppl.)S84\u2013S96.","journal-title":"Medical Journal of Ausstralia"},{"issue":"2","key":"e_1_3_2_119_1","first-page":"6","article-title":"Approaches to the enhancement of patient adherence to antidepressant medication treatment","volume":"61","author":"Delgado P L","year":"2000","unstructured":"118. Delgado P L. Approaches to the enhancement of patient adherence to antidepressant medication treatment. Journal of Clinical Psychiatry 2000; 61(Suppl.2)6\u20139.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.8.1195"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.9.1470"},{"key":"e_1_3_2_122_1","first-page":"53","article-title":"A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder","volume":"46","author":"Stark P","year":"1985","unstructured":"121. Stark P, Hardison C D. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 53\u201358.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_123_1","first-page":"409","article-title":"Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study","volume":"47","author":"Cohn J B","year":"1986","unstructured":"122. Cohn J B, Wilcox C S. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. Journal of Clinical Psychiatry 1986; 47: 409\u2013412.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.1.88"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110013002"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07190.x"},{"key":"e_1_3_2_127_1","first-page":"68","article-title":"Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression","volume":"25","author":"Lydiard R B","year":"1989","unstructured":"126. Lydiard R B, Laird L K, Morton W AJr, Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacology Bulletin 1989; 25: 68\u201370.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_128_1","first-page":"18","article-title":"Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression","volume":"51","author":"Reimherr F W","year":"1990","unstructured":"127. Reimherr F W, Chouinard G, Cohn C K, . Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. Journal of Clinical Psychiatry 1990; 51(Suppl. B)18\u201327.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_129_1","first-page":"234","article-title":"A double-blind comparison of nefazodone, imipramine, and placebo in major depression","volume":"55","author":"Fontaine R","year":"1994","unstructured":"128. Fontaine R, Ontiveros A, Elie R, . A double-blind comparison of nefazodone, imipramine, and placebo in major depression. Journal of Clinical Psychiatry 1994; 55: 234\u2013241.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_130_1","first-page":"104","article-title":"Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients","volume":"55","author":"Schweizer E","year":"1994","unstructured":"129. Schweizer E, Feighner J, Mandos L A, . Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. Journal of Clinical Psychiatry 1994; 55: 104\u2013108.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.6.802"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199400920-00005"},{"key":"e_1_3_2_133_1","first-page":"519","article-title":"A double-blind comparison of Org 3770, amitriptyline and placebo in major depression","volume":"56","author":"Bremner J D","year":"1995","unstructured":"132. Bremner J D. A double-blind comparison of Org 3770, amitriptyline and placebo in major depression. Journal of Clinical Psychiatry 1995; 56: 519\u2013525.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_134_1","first-page":"119","article-title":"Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients","volume":"11","author":"Fabre L","year":"1996","unstructured":"133. Fabre L, Birkhimer L J, Zaborny B A, Wong L F, Kapik B M. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients. International Clinical Psychopharmacology 1996; 11: 119\u2013127.","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"e_1_3_2_135_1","first-page":"15","article-title":"Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression","volume":"57","author":"Cohn C K","year":"1996","unstructured":"134. Cohn C K, Robinson D S, Roberts D L, . Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Journal of Clinical Psychiatry 1996; 57(Suppl.2)15\u201318.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb10136.x"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7224.1534"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb06353.x"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07188.x"},{"key":"e_1_3_2_140_1","first-page":"5","article-title":"The review of clinical safety data in a new drug application","volume":"25","author":"Laughren T P","year":"1989","unstructured":"139. Laughren T P. The review of clinical safety data in a new drug application. Psychopharmacology Bulletin 1989; 25: 5\u20138.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_141_1","first-page":"173","article-title":"Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression","volume":"26","author":"Dunlop S R","year":"1990","unstructured":"140. Dunlop S R, Dornseif B E, Wernicke J F, . Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression. Psychopharmacology Bulletin 1990; 26: 173\u2013180.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_142_1","first-page":"27","article-title":"A double-blind, placebo-controlled study of paroxetine in depressed outpatients","volume":"53","author":"Kiev A","year":"1992","unstructured":"141. Kiev A. A double-blind, placebo-controlled study of paroxetine in depressed outpatients. Journal of Clinical Psychiatry 1992; 53(Suppl.)27\u201329.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_143_1","first-page":"36","article-title":"A placebo-controlled trial of paroxetine in the treatment of major depression","volume":"53","author":"Smith W T","year":"1992","unstructured":"142. Smith W T, Glaudin V. A placebo-controlled trial of paroxetine in the treatment of major depression. Journal of Clinical Psychiatry 1992; 53: 36\u201339.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_144_1","first-page":"33","article-title":"The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients","volume":"53","author":"Claghorn J L","year":"1992","unstructured":"143. Claghorn J L. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients. Journal of Clinical Psychiatry 1992; 53(Suppl.)33\u201335.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300840-00007"},{"key":"e_1_3_2_146_1","first-page":"119","article-title":"Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients","volume":"11","author":"Fabre L BL","year":"1996","unstructured":"145. Fabre L BL, Birkhimer L J, Zaborny B A, Wong L F, Kapik B M. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients. International Clinical Psychopharmacology 1996; 11: 119\u2013127.","journal-title":"International Clinical Psychopharmacology"},{"key":"e_1_3_2_147_1","first-page":"8","article-title":"Reboxetine versus fluoxetine. an overview of efficacy and tolerability","volume":"59","author":"Massana J","year":"1998","unstructured":"146. Massana J. Reboxetine versus fluoxetine. an overview of efficacy and tolerability. Journal of Clinical Psychiatry 1998; 59(Suppl.)8\u201310.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(97)86377-8"},{"key":"e_1_3_2_149_1","first-page":"104","article-title":"Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients","volume":"55","author":"Schweizer E","year":"1994","unstructured":"148. Schweizer E, Feighner J, Mandos L A, Rickels K. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. Journal of Clinical Psychiatry 1994; 55: 104\u2013108.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0904"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0305"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199802000-00004"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00067-1"},{"key":"e_1_3_2_154_1","first-page":"191","article-title":"Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder","volume":"26","author":"Smith W T","year":"1990","unstructured":"153. Smith W T, Glaudin V, Panagides J, . Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacology Bulletin 1990; 26: 191\u2013196.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0508"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01173752"},{"key":"e_1_3_2_157_1","first-page":"68","article-title":"Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression","volume":"25","author":"Lydiard R B","year":"1989","unstructured":"156. Lydiard R B, Laird L K, Morton W AJr. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacology Bulletin 1989; 25: 68\u201370.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_2_158_1","first-page":"91","article-title":"Paroxetine in the treatment of melancholia and severe depression","volume":"7","author":"Tignol J","year":"1992","unstructured":"157. Tignol J, Stoker M J, Dunbar G C. Paroxetine in the treatment of melancholia and severe depression. International Clinical Psychopharmacology 1992; 7: 91\u201394.","journal-title":"International Clinical Psychopharmacology"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.12.1735"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199501004-00001"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015050-00003"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.160.4.519"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199409000-00001"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015010-00004"},{"issue":"2","key":"e_1_3_2_165_1","first-page":"53","article-title":"Nefazadone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability and effects on sexual function and satisfaction","volume":"57","author":"Feiger A","year":"1996","unstructured":"164. Feiger A, Kiev A, Shrivastava R K, Wisselink P G, Wilcox C S. Nefazadone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability and effects on sexual function and satisfaction. Journal of Clinical Psychiatry 1996; 57(Suppl.2)53\u201362.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_166_1","first-page":"369","article-title":"A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder","volume":"46","author":"Feighner J P","year":"1985","unstructured":"165. Feighner J P. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 369\u2013372.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_167_1","first-page":"821","article-title":"Fluoxetine versus amitriptyline in adult outpatients with major depression","volume":"45","author":"Fawcett J","year":"1989","unstructured":"166. Fawcett J, Zajecka J M, Kravitz H M, . Fluoxetine versus amitriptyline in adult outpatients with major depression. Current Therapeutic Research 1989; 45: 821\u2013831.","journal-title":"Current Therapeutic Research"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07192.x"},{"issue":"1","key":"e_1_3_2_169_1","first-page":"41","article-title":"A comparative trial of a new antidepressant, fluoxetine","volume":"4","author":"Levine S","year":"1989","unstructured":"168. Levine S, Deo R, Mahadevan K. A comparative trial of a new antidepressant, fluoxetine. International Clinical Psychopharmacology 1989; 4(Suppl.1)41\u201345.","journal-title":"International Clinical Psychopharmacology"},{"key":"e_1_3_2_170_1","first-page":"290","article-title":"A comparative trial of fluoxetine versus trazodone in outpatients with major depression","volume":"50","author":"Perry P J","year":"1989","unstructured":"169. Perry P J, Garvey M J, Kelly M W, Cook B L, Dunner F J, Winokur G. A comparative trial of fluoxetine versus trazodone in outpatients with major depression. Journal of Clinical Psychiatry 1989; 50: 290\u2013294.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90081-I"},{"key":"e_1_3_2_172_1","first-page":"3","article-title":"Fluoxetine: a comparative study with dothiepin","author":"Dowling B","year":"1990","unstructured":"171. Dowling B, Webb M GT, Halpin C M, . Fluoxetine: a comparative study with dothiepin. Irish Journal of Psychiatry 1990; Spring: 3\u20137.","journal-title":"Irish Journal of Psychiatry"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199100620-00007"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199206004-00009"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199206004-00008"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb03294.x"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199310000-00002"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300830-00002"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014346"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199403001-00007"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199400920-00005"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199408000-00003"},{"key":"e_1_3_2_183_1","first-page":"470","article-title":"Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression","volume":"18","author":"Staner L","year":"1995","unstructured":"182. Staner L, Kerkhofs M, Detroux D, . Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 1995; 18: 470\u2013477.","journal-title":"Sleep"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0305"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199705\/06)12:3<203::AID-HUP849>3.0.CO;2-V"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(97)71461-0"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(97)00418-5"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n1107"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.7.1024"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.1.76"},{"key":"e_1_3_2_191_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110001400108"},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(95)00292-8"},{"key":"e_1_3_2_193_1","first-page":"51","article-title":"A double-blind, randomised, 12-week comparison study of the safety and the efficacy of venlafaxine and fluoxetine in moderate to severe major depression in general practice","volume":"3","author":"Tylee A","year":"1997","unstructured":"192. Tylee A, Beaumont G, Bowden M W, . A double-blind, randomised, 12-week comparison study of the safety and the efficacy of venlafaxine and fluoxetine in moderate to severe major depression in general practice. Primary Care Psychiatry 1997; 3: 51\u201358.","journal-title":"Primary Care Psychiatry"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0703"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.1.12"},{"key":"e_1_3_2_196_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0204"},{"key":"e_1_3_2_197_1","first-page":"173","article-title":"A 6-week randomised, double-blind multicentre trial in hospitalised depressed patients","volume":"10","author":"Zivlov M","year":"1995","unstructured":"196. Zivlov M, de Jongh G D. A 6-week randomised, double-blind multicentre trial in hospitalised depressed patients. Human Psychopharmacology 1995; 10: 173\u2013180.","journal-title":"Human Psychopharmacology"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470100807"},{"key":"e_1_3_2_199_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470100403"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00092-4"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199417001-00007"},{"key":"e_1_3_2_202_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199705000-00007"},{"key":"e_1_3_2_203_1","first-page":"118","article-title":"Moclobemide versus fluoxetine in the treatment of major depressive disorders in adults","volume":"22","author":"Lapierre Y D","year":"1997","unstructured":"202. Lapierre Y D, Joffe R, McKenna K, . Moclobemide versus fluoxetine in the treatment of major depressive disorders in adults. Journal of Psychiaty and Neuroscience 1997; 22: 118\u2013126.","journal-title":"Journal of Psychiaty and Neuroscience"},{"key":"e_1_3_2_204_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422001"},{"key":"e_1_3_2_205_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.1.80"},{"key":"e_1_3_2_206_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.9.1372"},{"key":"e_1_3_2_207_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199608000-00006"},{"key":"e_1_3_2_208_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.126.4.457"},{"key":"e_1_3_2_209_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.1.34"},{"key":"e_1_3_2_210_1","first-page":"385","article-title":"Treatment of imipramine-resistant recurrent depression. II. An open clinical trial of lithium augmentation","volume":"50","author":"Thase M E","year":"1989","unstructured":"209. Thase M E, Kupfer D J, Frank E, Jarrett D B. Treatment of imipramine-resistant recurrent depression. II. An open clinical trial of lithium augmentation. Journal of Clinical Psychiatry 1989; 50: 385\u2013388.","journal-title":"Journal of Clinical Psychiatry"},{"key":"e_1_3_2_211_1","first-page":"655","article-title":"Failure of 1-triiodothyronine to potentiate tricylic antidepressant response","volume":"23","author":"Steiner M","year":"1978","unstructured":"210. Steiner M, Radwan M, Elizur A, Blum I, Atsmon A, Davidson S. Failure of 1-triiodothyronine to potentiate tricylic antidepressant response. Current Therapeutic Research 1978; 23: 655\u2013659.","journal-title":"Current Therapeutic Research"},{"key":"e_1_3_2_212_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820170065008"},{"key":"e_1_3_2_213_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.4.375"},{"key":"e_1_3_2_214_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950030084009"},{"key":"e_1_3_2_215_1","doi-asserted-by":"publisher","DOI":"10.2190\/6T1E-A6E1-V2J6-JL99"},{"key":"e_1_3_2_216_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.10.1346"},{"key":"e_1_3_2_217_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199703000-00003"},{"key":"e_1_3_2_218_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.1.37"},{"key":"e_1_3_2_219_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1005"},{"key":"e_1_3_2_220_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00627-3"},{"key":"e_1_3_2_221_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015020-00007"},{"key":"e_1_3_2_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)08007-5"},{"key":"e_1_3_2_223_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199712000-00002"},{"key":"e_1_3_2_224_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00004"},{"key":"e_1_3_2_225_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199904000-00014"},{"key":"e_1_3_2_226_1","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000297328"},{"key":"e_1_3_2_227_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300830-00008"},{"key":"e_1_3_2_228_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199503001-00006"},{"key":"e_1_3_2_229_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199300830-00009"},{"key":"e_1_3_2_230_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00009"},{"key":"e_1_3_2_231_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780260035003"},{"key":"e_1_3_2_232_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810240013002"},{"key":"e_1_3_2_233_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.9.1295"},{"key":"e_1_3_2_234_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.9.829"},{"key":"e_1_3_2_235_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.4.328"},{"key":"e_1_3_2_236_1","first-page":"250","article-title":"Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung","volume":"10","author":"Halama P","year":"1991","unstructured":"235. Halama P. Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung. Nervenheilkunde 1991; 10: 250\u2013253.","journal-title":"Nervenheilkunde"},{"key":"e_1_3_2_237_1","first-page":"1576","article-title":"Hypericum-Extrakt bei depressionen \u2013eine wirksame alternative","volume":"42","author":"Reh C","year":"1992","unstructured":"236. Reh C, Laux P, Schenk N. Hypericum-Extrakt bei depressionen \u2013eine wirksame alternative. Therapiewoche 1992; 42: 1576\u20131581.","journal-title":"Therapiewoche"},{"key":"e_1_3_2_238_1","doi-asserted-by":"publisher","DOI":"10.1177\/089198879400701s06"},{"key":"e_1_3_2_239_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979346"},{"key":"e_1_3_2_240_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<163::AID-HUP5>3.0.CO;2-I"},{"key":"e_1_3_2_241_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7260.536"},{"key":"e_1_3_2_242_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.15.1978"},{"key":"e_1_3_2_243_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.8.1361"},{"key":"e_1_3_2_244_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.14.1807"},{"key":"e_1_3_2_245_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015020-00001"},{"key":"e_1_3_2_246_1","doi-asserted-by":"publisher","DOI":"10.1177\/089198879400701s08"},{"key":"e_1_3_2_247_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979523"},{"key":"e_1_3_2_248_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979524"}],"container-title":["Australian &amp; New Zealand Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/j.1440-1614.2004.01377.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/j.1440-1614.2004.01377.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/j.1440-1614.2004.01377.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:50:28Z","timestamp":1777373428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/j.1440-1614.2004.01377.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":247,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1080\/j.1440-1614.2004.01377.x"],"URL":"https:\/\/doi.org\/10.1080\/j.1440-1614.2004.01377.x","relation":{},"ISSN":["0004-8674","1440-1614"],"issn-type":[{"value":"0004-8674","type":"print"},{"value":"1440-1614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}